SCM lands Buccolam trial supply contract
SCM Pharma will make trial supplies of Auralis’ trail stage childhood epilepsy drug Buccolam, under a new manufacturing contract announced this week.
SCM Pharma will make trial supplies of Auralis’ trail stage childhood epilepsy drug Buccolam, under a new manufacturing contract announced this week.
Stratophase and GSK are part of a consortium developing a multi-parameter device capable of performing the real-time monitoring of key criteria needed to employ QbD in API production.
A significant share of contract API maker ScinoPharm Taiwan is set to change hands after Watson Pharmaceuticals decided to sell its stake to Uni-President Enterprises Corporation.
PARI Respiratory Equipment has launched its Vios aerosol delivery system to provide a tool for quickly administering treatments to the lungs, with a small particle size and high respirable drug dose.
Merrion Pharmaceuticals’ GIPET technology has been granted US patent protection for use with bisphosphonates.
WuXi PharmaTech is collaborating with J&J Pharmaceutical R&D, providing the pharma with toxicology services and receiving training to establish GLP at its facility in Suzhou, China.
US CRO PPD has been busy on both sides of the Atlantic, opening a clinical testing facility in Ireland and, in the US, moving forward with plans to spin-off its compound partnering business as Furiex Pharmaceuticals